Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer

British Journal of Cancer

Volumn 104, Issue 1, 2011, Pages 51-59

  Volkova, E ^a   Willis, J A ^b   Wells, J E ^a   Robinson, B A ^a,b   Dachs, G U ^a   Currie, M J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

angiopoietin 2; C reactive protein; insulin resistance; obesity; tumour angiogenesis

Indexed keywords

ANGIOPOIETIN 2; C PEPTIDE; C REACTIVE PROTEIN; SOMATOMEDIN; SOMATOMEDIN C; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ANTHROPOMETRIC PARAMETERS; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; INSULIN RESISTANCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; BODY MASS INDEX; C-PEPTIDE; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650924656     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6606005     Document Type: Article

References (55)

1. Ahmad SA, Liu W, Jung YD, Fan F, Reinmuth N, Bucana CD, Ellis LM (2001a) Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis. Cancer 92: 1138-1143
2. Ahmad SA, Liu W, Jung YD, Fan F, Wilson M, Reinmuth N, Shaheen RM, Bucana CD, Ellis LM (2001b) The effect of angiopoietin-1 and-2 on tumor growth and angiogenesis in human colon cancer. Cancer Res 61: 1255-1259
3. Bello G, Cailotto F, Hanriot D, Kolopp-Sarda MN, Latger-Cannard V, Hess K, Zannad F, Longrois D, Ropars A (2008) C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway. Atherosclerosis 200: 286-293
4. Birmingham JM, Busik JV, Hanses-Smith FM, Fenton JI (2009) Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis 30: 690-697
5. Cao D, Hou M, Guan YS, Jiang M, Yang Y, Gou HF (2009) Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer 9: 432
6. Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59: 366-378
7. Census (2006) QuickStats about Canterbury region, http://www.stats.govt. nz/Census/2006CensusHomePage/QuickStats/AboutAPlace/SnapShot.aspx? typeregin&ParentID&tabCulturaldiversity&id1000013, accessed 21 April 2010
8. Chung YC, Hou YC, Chang CN, Hseu TH (2006) Expression and prognostic significance of angiopoietin in colorectal carcinoma. J Surg Oncol 94: 631-638
9. Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, Urbich C, Biswas SK, Murdoch C, Plate KH, Reiss Y, Lewis CE, Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, Urbich C, Biswas SK, Murdoch C, Plate KH, Reiss Y, Lewis CE (2010) Angiopoietin-2 regulates gene expression in TIE2- expressing monocytes and augments their inherent proangiogenic functions. Cancer Res 70: 5270-5280
10. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25: 4-7
11. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, Wolmark N (2006) Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98: 1647-1654
12. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239
13. Frizelle F (2009) Cancer in New Zealand. N Z Med J 122: 7-9
14. Fuchs CS, Goldberg RM, Sargent DJ, Meyerhardt JA, Wolpin BM, Green EM, Pitot HC, Pollak M (2008) Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. Clin Cancer Res 14: 8263-8268
15. Ganta VC, Cromer W, Maills GL, Traylor J, Jennings M, Daley S, Clark B, Mathis JM, Bernas M, Boktor M, Jordan P, Witte M, Alexander JS (2010) Angiopoietin-2 in experimental colitis. Inflamm Bowel Dis 16: 1029-1039
16. Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86: 836-842
17. Goede V, Coutelle O, Neuneier J, Reinacher-Schick A, Schnell R, Koslowsky TC, Weihrauch MR, Cremer B, Kashkar H, Odenthal M, Augustin HG, Schmiegel W, Hallek M, Hacker UT (2010) Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. Br J Cancer 103: 1407-1414
18. Gonullu G, Kahraman H, Bedir A, Bektas A, Yücel I (2009) Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis 25: 205-212
19. Greenberg AS, Obin MS (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83: 461-465
20. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (eds). (2002) AJCC Cancer Staging Manual, 6th edn, Lippincott Raven Publishers: Philadelphia
21. Haydon AMM, MacInnis RJ, English DR, Giles GG (2006) Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 55: 62-67
22. Helfrich I, Edler L, Sucker A, Thomas M, Christian S, Schadendorf D, Augustin HG (2009) Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin Cancer Res 15: 1384-1392
23. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792
24. Komninou D, Ayonote A, Richie JP, Rigas B (2003) Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med 228: 396-405
25. Koukourakis MI, Kambouromiti G, Pitsiava D, Tsousou P, Tsiarkatsi M, Kartalis G (2009) Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by antihypertensive medication. Inflammation 32: 169-175
26. Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau S-W, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM (2008) Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26: 4072-4077
27. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436-444
28. Merkow RP, Bilimoria KY, Cohen ME, Richards K, Ko CY, Hall BL (2009) Variability in reoperation rates at 182 hospitals: a potential target for quality improvement. J Am Coll Surg 209: 557-564
29. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson III AB, Macdonald JS, Fuchs CS (2003) Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98: 484-495
30. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Nelson H, Whittom R, Hantel A, Thomas J, Fuchs CS (2008) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from cancer and leukemia group B 89803. J Clin Oncol 26: 4109-4115
31. Ministry of Health (2007) Diabetes surveillance: population-based estimates and projections for New Zealand, 2001-2011: Public Health Intelligence Occasional Bulletin No. 46. Ministry of Health: Wellington. http://www.moh.govt.nz/moh.nsf/indexmh/diabetes-suveillance-populationestimates- projections-2001-2011, accessed 21 April 2010
32. Ministry of Health(2008) A Portrait of Health. Key Results of the 2006/07 New Zealand Health Survey. Ministry of Health: Wellington
33. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70 000 events. Cancer Epidemiol Biomarkers Prev 16: 2533-2547
34. Moon HG, Ju YT, Jeong CY, Jung EJ, Lee YJ, Hong SC, Ha WS, Park ST, Choi SK (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15: 1918-1922
35. Morrin H, Gunningham S, Currie M, Dachs G, Fox S, Robinson B (2005) The Christchurch Tissue Bank to support cancer research. N Z Med J 118: U1735
36. Murdoch C, Tazzyman S, Webster S, Lewis CE (2007) Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 178: 7405-7411
37. Nguyen XM, Lane J, Smith BR, Nguyen NT (2009) Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. J Gastrointest Surg 13: 1205-1212
38. Nozoe T, Matsumata T, Kitamura M, Sugimachi K (1998) Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 176: 335-338
39. Nozoe T, Mori E, Takahashi I, Ezaki T (2008) Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today 38: 597-602
40. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL (2009) Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 15: 5141-5148
41. Park EJ, Lee JH, Yu G-Y, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140: 197-208
42. Park JH, Park KJ, Kim YS, Sheen SS, Lee KS, Lee HN, Oh YJ, Hwang SC (2007) Serum angiopoietin-2 as a clinical marker for lung cancer. Chest 132: 200-206
43. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
44. Porta C, Larghi P, Rimoldi M, Grazia Totaro M, Allavena P, Mantovani A, Sica A (2009) Cellular and molecular pathways linking inflammation and cancer. Immunobiology 214: 761-777
45. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335: 1-11
46. Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, Jung YD, Bucana CD, Radinsky R, Gallick GE, Ellis LM (2002) Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82: 1377-1389 (Pubitemid 35191541)
47. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565
48. Rmali KA, Puntis MCA, Jiang WG (2006) Tumour-associated angiogenesis in human colorectal cancer. Colorectal Dis 9: 3-14
49. Sandhu MS, Dunger DB, Giovannucci EL (2002) Insulin, insulin-like growth factor-1 (IGF-1), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94: 972-980
50. Sarraf-Yazdi S, Mi J, Moeller BJ, Niu X, White RR, Kontos CD, Sullenger BA, Denwhirst MW, Clary BM (2008) Inhibition of in vivo tumour angiogenesis and growth via systemic delivery of angiopoietin 2-specific RNA aptamer. J Surg Res 146: 16-23
51. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10: 937-941
52. Tsujinaka S, Konishi F, Kawamura YJ, Saito M, Tajima N, Tanaka O, Lefor AT (2008) Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 51: 1757-1765
53. Turu MM, Slevin M, Matou S, West D, Rodríguez C, Luque A, Grau- Olivares M, Badimon L, Martinez-Gonzalez J, Krupinski J (2008) Creactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biol 9: 47
54. Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL, Fuchs CS (2009) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 27: 176-185
55. Yang H, Nan B, Yan S, Li M, Yao Q, Chen C (2005) C-reactive protein decreases expression of the VEGF receptors and neuropilins and inhibits VEGF165-induced cell proliferation in human endothelial cells. Biochem Biophys Res Commun 333: 1003-1010